Logo

Mangalam Drugs&Org. Share Price

Mangalam Drugs&Org. (INR)111.36-4   (-3.4%)

Exchange ScripsBSE532637NSEMANGALAMISININE584F01014

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Mangalam Drugs&Org. Performance

Market performance
Open price115.32
High116.89
Volumes20370
Prev Close111.36
Low110.91
Closing date2025-01-10
Historical performance
1 Year High144.99
3 Year High173.00
5 Year High196.95
1 Year Low90.80
3 Year Low90.80
5 Year Low20.65

Mangalam Drugs&Org. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
176
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-19.43
Dividend Yield
Dividend Yield
N/A

Mangalam Drugs&Org. Investment Returns

1 Year
4.6%
3 Years
-17.9%
5 Years
266.9%
10 Years
444.5%

Mangalam Drugs&Org. Technicals

IndicatorsValueSignal
5-DMA113.47Bearish
10-DMA116.01Bearish
20-DMA115.9Bearish
50-DMA113.66Bearish
100-DMA119.38Bearish
200-DMA112.24Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1818181818
Foreign Investors---------------
Domestic Investors1818181818
Public Investors1949019294191551859217960
Government---------------

Mangalam Drugs&Org. Financials

Below figures are in Rs. Crores

ParticularsMar-2024
Other Income1
Operating Profit175
Interest139
Depreciation147
Profit Before Tax-111
Consolidated Net Profit-91
Adjusted EPS-6

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024
Share Capital158
Total Reserves1200
Minority Interest---
Total Non-Current Liabilities338
Total Liabilities3337
Capital Work in Progress---
Total Assets3337

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024
Cash Flow from Operating Activities39
Cash Flow from Investing Activities-118
Cash Flow from Financing Activitie52
Net Cash Inflow / Outflow-27
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -19.43.
  • 3Y Stock Price CAGR of the stock is -7.8.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹175 Million.
  • The company generated revenue of ₹3686 Million in the previous financial year.

Mangalam Drugs&Org.

111.36-4   (-3.4%)

Investment Amount: ₹ 10535
Current Value: ₹ 11136
Performance: 5.7%
P/L: ₹ 601
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month